Estimated Vaccination Coverage*,† with Selected Vaccines Among Adolescents Aged 13-17 Years§ Living Below the Poverty Level¶by State and Local Area -- National Immunization Survey-Teen, United States, 2008
  >2 MMR**
% (95% CI)
>3 HepB††
% (95% CI)
>1 Var§§
% (95% CI)
>1 Td or Tdap¶¶
% (95% CI)
>1 Tdap***
% (95% CI)
>1 MCV4†††
% (95% CI)
>1 HPV4§§§
% (95% CI)
US National87.1 (84.1-89.6) 86.7 (83.9-89.1) 77.0 (71.1-82.1) 70.9 (67.0-74.4) 38.6 (34.2-43.2) 40.8 (36.6-45.2) 46.4 (39.8-53.1)
Alabama91.0 (79.0-96.4) 68.6 (54.4-80.1) 54.1 (33.6-73.2) 78.8 (65.7-87.9) 56.2 (42.3-69.2) 40.5 (27.8-54.6) NA
Alaska82.9 (62.2-93.5) 89.8 (74.4-96.4) NA 75.5 (55.3-88.4) 42.6 (26.2-60.9) 39.2 (23.3-57.7) NA
Arizona77.2 (55.1-90.3) 84.9 (66.4-94.1) NA 65.7 (43.4-82.7) 44.2 (27.2-62.6) 45.4 (28.1-63.9) NA
Arkansas91.7 (79.9-96.8) 93.5 (82.9-97.7) NA 54.4 (40.0-68.2) 24.1 (13.7-38.7) NA NA
California89.0 (75.1-95.6) 86.0 (72.1-93.6) NA 75.9 (59.8-87.0) 51.0 (33.6-68.2) 53.7 (35.7-70.8) NA
ColoradoNA NA NA NA NA NA NA
ConnecticutNA NA NA NA NA NA NA
DelawareNA NA NA NA NA NA NA
District of Columbia92.7 (77.1-98.0) 92.4 (79.7-97.4) 96.0 (82.1-99.2) 89.5 (81.1-94.5) 27.6 (17.9-40.0) 56.3 (43.4-68.3) 47.3 (29.3-66.0)
Florida87.9 (57.6-97.5) 98.7 (91.1-99.8) NA 85.9 (56.9-96.6) NA 37.4 (20.2-58.4) NA
Georgia95.0 (86.8-98.2) 92.9 (82.0-97.4) NA 61.8 (45.6-75.7) 34.4 (20.1-52.1) 39.1 (23.7-57.0) NA
Hawaii90.0 (72.1-96.9) 85.9 (66.1-95.0) NA 58.5 (39.2-75.4) NA 46.1 (28.3-65.0) NA
IdahoNA NA NA NA NA NA NA
Illinois92.4 (87.5-95.5) 96.6 (93.6-98.3) 82.6 (70.8-90.2) 65.9 (50.8-78.4) 45.8 (32.6-59.7) 41.1 (28.4-55.2) NA
   IL-City of Chicago84.2 (75.3-90.3) 93.1 (86.9-96.5) 73.1 (57.5-84.5) 66.4 (55.0-76.1) 38.7 (28.3-50.3) 42.0 (31.3-53.6) 30.5 (16.5-49.4)
   IL-Rest of State98.7 (95.4-99.7) 99.3 (96.9-99.9) NA 65.6 (40.1-84.4) 51.4 (29.4-72.9) 40.4 (21.0-63.5) NA
Indiana92.7 (83.7-97.0) 98.2 (93.0-99.6) NA 37.2 (23.2-53.7) NA 25.7 (14.1-42.0) NA
IowaNA NA NA NA NA NA NA
KansasNA NA NA NA NA NA NA
Kentucky97.6 (90.0-99.4) 96.9 (80.8-99.6) NA 84.5 (66.8-93.7) NA NA NA
Louisiana90.2 (77.9-96.0) 89.5 (77.6-95.5) NA 77.4 (64.1-86.9) 32.7 (20.8-47.4) 67.3 (53.3-78.8) NA
MaineNA NA NA NA NA NA NA
Maryland87.0 (69.6-95.2) 86.7 (70.7-94.7) NA 89.0 (72.7-96.1) 37.8 (19.9-59.7) 71.4 (52.2-85.1) NA
MassachusettsNA NA NA NA NA NA NA
Michigan96.8 (86.8-99.3) 95.6 (86.1-98.7) NA 59.4 (40.6-75.9) NA 34.3 (18.8-54.2) NA
MinnesotaNA NA NA NA NA NA NA
Mississippi93.5 (85.4-97.3) 52.6 (40.3-64.6) NA 31.3 (20.8-44.2) 26.6 (16.8-39.4) NA NA
Missouri77.9 (56.2-90.6) 84.6 (65.4-94.1) NA 55.9 (37.4-73.0) 41.6 (24.5-61.1) 36.6 (20.0-57.0) NA
MontanaNA NA NA NA NA NA NA
NebraskaNA NA NA NA NA NA NA
Nevada86.9 (72.6-94.3) 79.6 (63.4-89.8) NA 71.3 (53.8-84.2) 46.5 (30.2-63.6) 40.3 (24.4-58.4) NA
New HampshireNA NA NA NA NA NA NA
New JerseyNA NA NA NA NA NA NA
New Mexico83.3 (68.6-92.0) 77.9 (61.3-88.7) NA 79.3 (61.4-90.2) 53.2 (37.2-68.6) 48.1 (32.7-63.9) NA
New York87.4 (78.6-93.0) 80.6 (67.3-89.3) 96.4 (88.3-99.0) 87.1 (77.0-93.1) 52.3 (39.2-65.2) 47.5 (34.6-60.7) 62.8 (44.1-78.3)
   NY-City of New York83.9 (72.1-91.3) 82.8 (70.9-90.5) 95.4 (85.3-98.7) 87.8 (76.9-93.9) 57.0 (42.4-70.4) 49.8 (35.6-64.1) 64.7 (44.5-80.6)
   NY-Rest of StateNA NA NA NA NA NA NA
North Carolina89.2 (72.6-96.2) 85.5 (62.2-95.5) NA 60.8 (39.2-78.9) NA NA NA
North DakotaNA NA NA NA NA NA NA
OhioNA NA NA NA NA NA NA
Oklahoma87.0 (69.5-95.1) 88.7 (68.4-96.6) NA 70.1 (53.5-82.7) 32.7 (19.4-49.5) 28.5 (16.1-45.3) NA
OregonNA NA NA NA NA NA NA
Pennsylvania93.3 (86.7-96.8) 94.4 (87.4-97.6) 89.8 (73.3-96.6) 80.3 (62.7-90.8) 51.1 (35.4-66.6) 59.5 (42.9-74.1) 35.0 (18.6-56.1)
   PA-Philadelphia County84.2 (74.8-90.6) 87.6 (77.6-93.6) 88.5 (74.2-95.3) 79.0 (67.5-87.1) 42.9 (31.1-55.5) 65.8 (53.8-76.0) 60.5 (43.2-75.5)
   PA-Rest of StateNA NA NA NA NA NA NA
Rhode IslandNA NA NA NA NA NA NA
South Carolina88.4 (77.6-94.4) 90.1 (78.2-95.8) NA 42.9 (29.2-57.9) 21.7 (12.1-35.7) 32.0 (19.7-47.6) NA
South Dakota91.2 (77.0-97.0) 68.9 (49.4-83.4) NA 49.6 (30.9-68.4) NA NA NA
Tennessee87.4 (68.0-95.8) 90.4 (77.3-96.3) NA 54.8 (36.5-71.8) 37.5 (21.9-56.3) 43.3 (26.4-61.9) NA
Texas82.0 (70.0-89.9) 85.7 (74.7-92.4) 68.5 (45.5-84.9) 80.1 (67.7-88.6) 34.9 (22.9-49.3) 33.2 (22.4-46.0) 35.5 (19.1-56.3)
   TX-Bexar County82.3 (62.9-92.7) 74.5 (52.0-88.8) NA 68.5 (49.6-82.8) 45.8 (29.0-63.5) 42.9 (26.7-60.8) NA
   TX-City of Houston84.3 (70.0-92.5) 81.4 (66.5-90.6) NA 73.2 (58.6-84.1) 41.8 (27.1-58.1) 53.4 (38.0-68.1) NA
   TX-Rest of State81.7 (67.1-90.7) 86.9 (73.2-94.2) 66.0 (40.6-84.7) 81.8 (66.5-91.0) 33.3 (19.6-50.5) 29.9 (18.1-45.0) NA
UtahNA NA NA NA NA NA NA
VermontNA NA NA NA NA NA NA
VirginiaNA NA NA NA NA NA NA
WashingtonNA NA NA NA NA NA NA
West Virginia82.4 (67.2-91.4) 78.1 (62.2-88.6) NA 48.4 (33.3-63.9) 22.8 (12.2-38.4) 31.2 (18.9-46.8) NA
WisconsinNA NA NA NA NA NA NA
WyomingNA NA NA NA NA NA NA

 
* Estimate presented as point estimate (%) ± 95% confidence interval (CI). Estimate=NA (Not Available) if the unweighted sample size for the denominator was <30 or (CI half width)/Estimate > 0.6.
† Estimate may be unreliable; (CI width) >20.
§ Adolescents in the 2008 NIS-Teen were born during January 1990 - February 1996. Vaccination coverage estimates include only adolescents who had adequately complete provider-reported immunization records.
¶ Poverty status was based on 2007 U.S. Census poverty thresholds (available at http://www.census.gov/hhes/www/poverty.html).
** Includes > 2 doses of measles-mumps-rubella vaccine
†† Includes >3 doses of hepatitis B vaccine.
§§ Includes > 1 dose of varicella vaccine among adolescents without a history of varicella disease.
¶¶ Includes > 1 dose of tetanus toxoid-diphtheria vaccine (Td) or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years.
*** Includes >1 tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years.
††† Includes percentages receiving meningococcal conjugate vaccine (MCV4) and meningococcal -unknown type vaccine.
§§§ Quadrivalent human papillomavirus vaccine. Percentages reported among females only since HPV4 vaccine is only recommended for females.
tab04_iap_bpov